Stock-Based Compensation for Bristol-Myers Squibb (BMY)
Stock-Based Compensation for Bristol-Myers Squibb (BMY): headline value $553.00M · YoY +9.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingStock-Based CompensationSwitch metric
Latest period
$553.00M
YoY change
+9.1%
5Y CAGR
-6.6%
Peak year (2020)
$779.00M
Latest annual
$553.00M
Stock-Based Compensation history chart for Bristol-Myers Squibb (BMY) from 1989 to 2025
Stock-Based Compensation history table for Bristol-Myers Squibb (BMY) from 1989 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $553.00M | +9.1% | ||
| 2024 | $507.00M | -2.1% | ||
| 2023 | $518.00M | +13.3% | ||
| 2022 | $457.00M | -21.6% | ||
| 2021 | $583.00M | -25.2% | ||
| 2020 | $779.00M | +76.6% | ||
| 2019 | $441.00M | +99.5% | ||
| 2018 | $221.00M | +11.1% | ||
| 2017 | $199.00M | -2.9% | ||
| 2016 | $205.00M | -12.8% | ||
| 2015 | $235.00M | +10.3% | ||
| 2014 | $213.00M | +11.5% | ||
| 2013 | $191.00M | +24.0% | ||
| 2012 | $154.00M | -4.3% | ||
| 2011 | $161.00M | -16.6% | ||
| 2010 | $193.00M | +5.5% | ||
| 2009 | $183.00M | +1.1% | ||
| 2008 | $181.00M | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — |
Stock-Based Compensation values are taken from Bristol-Myers Squibb's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bristol-Myers Squibb (BMY) most recent annual stock-based compensation stands at $553.00M (2025) – grew 9.1% year-over-year.
Bristol-Myers Squibb stock-based compensation has contracted on net over the period, with a -6.6% compound annual growth rate over 2020–2025 (5 years).
Across the available history, stock-based compensation reached its high of $779.00M in 2020 and its low of $0 in 1989.
Bristol-Myers Squibb (BMY) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Bristol-Myers Squibb Stock-Based Compensation by Year
Bristol-Myers Squibb Stock-Based Compensation 2025: $553.00M
Bristol-Myers Squibb stock-based compensation in 2025 was $553.00M, grew 9.1% from 2024.
Bristol-Myers Squibb Stock-Based Compensation 2024: $507.00M
Bristol-Myers Squibb stock-based compensation in 2024 was $507.00M, edged down 2.1% below 2023.
Bristol-Myers Squibb Stock-Based Compensation 2023: $518.00M
Bristol-Myers Squibb stock-based compensation in 2023 was $518.00M, grew 13.3% from 2022.
Bristol-Myers Squibb Stock-Based Compensation 2022: $457.00M
Bristol-Myers Squibb stock-based compensation in 2022 was $457.00M, declined 21.6% below 2021.
Bristol-Myers Squibb Stock-Based Compensation 2021: $583.00M
Bristol-Myers Squibb stock-based compensation in 2021 was $583.00M.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Stock-Based Compensation
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's stock-based compensation?
Latest reported stock-based compensation for Bristol-Myers Squibb (BMY) is $553.00M (period ending December 31, 2025).
How has Bristol-Myers Squibb stock-based compensation changed year-over-year?
Bristol-Myers Squibb (BMY) stock-based compensation changed +9.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb stock-based compensation?
Bristol-Myers Squibb (BMY) stock-based compensation compound annual growth rate is -6.6% over the most recent 5 years available.
When did Bristol-Myers Squibb stock-based compensation hit its highest annual value?
Bristol-Myers Squibb stock-based compensation reached its highest annual value of $779.00M in 2020.
What was Bristol-Myers Squibb stock-based compensation in 2024?
Bristol-Myers Squibb (BMY) stock-based compensation in 2024 was $507.00M.
What was Bristol-Myers Squibb stock-based compensation in 2025?
Bristol-Myers Squibb (BMY) stock-based compensation in 2025 was $553.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.